Solensky Gerald JR 4
4 · Zomedica Pharmaceuticals Corp. · Filed Apr 2, 2019
Insider Transaction Report
Form 4
Solensky Gerald JR
DirectorPresident and CEO10% Owner
Transactions
- Exercise/Conversion
Common Shares, without par value
2019-03-29$1.52/sh+65,789$99,999→ 38,545,671 total - Exercise/Conversion
Stock Option (right to buy)
2019-03-29−65,789→ 1,705,265 totalExercise: $1.52From: 2019-01-10Exp: 2021-01-10→ Common Shares, without par value (65,789 underlying)